Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group Cannabis, Life Science
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®) Life Science
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs Life Science
Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors Life Science
Trump Medicare plan promises lower prescription prices for seniors, but also risks losing coverage of some critical cancer, HIV, depression drugs Life Science
Amazon confirms it’s working on a project to mine patient records and more accurately diagnose diseases Life Science